SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 27 filers reported holding SPRING BK PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $245,000 | -9.3% | 183,508 | +0.0% | 0.00% | – |
| Q2 2020 | $270,000 | +34.3% | 183,490 | -15.4% | 0.00% | – |
| Q1 2020 | $201,000 | -40.9% | 216,977 | +0.9% | 0.00% | – |
| Q4 2019 | $340,000 | -52.6% | 215,114 | +3.0% | 0.00% | – |
| Q3 2019 | $718,000 | -4.4% | 208,825 | +2.6% | 0.00% | – |
| Q2 2019 | $751,000 | -89.5% | 203,573 | -70.3% | 0.00% | – |
| Q1 2019 | $7,184,000 | +2.4% | 684,927 | +1.4% | 0.00% | – |
| Q4 2018 | $7,017,000 | -3.6% | 675,333 | +11.8% | 0.00% | – |
| Q3 2018 | $7,279,000 | +27.1% | 604,067 | +25.0% | 0.00% | – |
| Q2 2018 | $5,727,000 | +1131.6% | 483,258 | +1498.8% | 0.00% | – |
| Q1 2018 | $465,000 | +5.0% | 30,226 | -8.3% | 0.00% | – |
| Q4 2017 | $443,000 | -8.3% | 32,961 | +14.8% | 0.00% | – |
| Q3 2017 | $483,000 | +67.7% | 28,702 | +34.7% | 0.00% | – |
| Q2 2017 | $288,000 | +28700.0% | 21,314 | +12976.1% | 0.00% | – |
| Q1 2017 | $1,000 | – | 163 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 615,384 | $8,332,000 | 1.29% |
| RTW INVESTMENTS, LP | 250,000 | $3,385,000 | 0.71% |
| Monashee Investment Management LLC | 100,000 | $1,354,000 | 0.57% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 275,728 | $3,733,000 | 0.46% |
| SPHERA FUNDS MANAGEMENT LTD. | 175,000 | $2,370,000 | 0.40% |
| TIEDEMANN ADVISORS, LLC | 362,049 | $4,902,000 | 0.36% |
| Morse Asset Management, Inc | 63,700 | $862,000 | 0.28% |
| Private Capital Advisors, Inc. | 56,250 | $762,000 | 0.25% |
| Crestline Management, LP | 98,581 | $1,335,000 | 0.18% |
| SECTORAL ASSET MANAGEMENT INC | 112,500 | $1,523,000 | 0.17% |